Phase II study of S-1/paclitaxel combination therapy in patients with previously treated non-small cell lung cancer
Phase 2
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000035812
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1: Cases with serious complications Interstitial pneumonia Serious heart disease diabetes which is difficult to control Serious infectious diseases 2: Cases with other active organs and overlapping cancers 3: Patients with a history of severe hypersensitivity 4: Case in which flucytosine is being administered 5) Cases with a history of alcohol hypersensitivity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall response rate
- Secondary Outcome Measures
Name Time Method Progression-free survival Overall survival safety